Preinvasive  ||| S:0 E:12 ||| JJ
lesions  ||| S:12 E:20 ||| NNS
in  ||| S:20 E:23 ||| IN
gynecology -   ||| S:23 E:37 ||| CD
vulva  ||| S:37 E:43 ||| NN
For  ||| S:43 E:47 ||| IN
preinvasive  ||| S:47 E:59 ||| JJ
lesions  ||| S:59 E:67 ||| NNS
of  ||| S:67 E:70 ||| IN
vulva ||| S:70 E:75 ||| NN
,  ||| S:75 E:77 ||| ,
a  ||| S:77 E:79 ||| DT
common  ||| S:79 E:86 ||| JJ
term  ||| S:86 E:91 ||| NN
VIN  ||| S:91 E:95 ||| FW
-   ||| S:95 E:98 ||| FW
vulval  ||| S:98 E:105 ||| FW
intraepithelial  ||| S:105 E:121 ||| FW
neoplasia  ||| S:121 E:131 ||| FW
is  ||| S:131 E:134 ||| VBZ
used ||| S:134 E:138 ||| VBN
.  ||| S:138 E:140 ||| .
VIN  ||| S:140 E:144 ||| NNP
is  ||| S:144 E:147 ||| VBZ
a  ||| S:147 E:149 ||| DT
histological  ||| S:149 E:162 ||| JJ
dia-gnosis  ||| S:162 E:173 ||| NN
based  ||| S:173 E:179 ||| VBN
on  ||| S:179 E:182 ||| IN
abnormal  ||| S:182 E:191 ||| JJ
squamous  ||| S:191 E:200 ||| JJ
epithelial  ||| S:200 E:211 ||| JJ
proliferation ||| S:211 E:224 ||| NN
.  ||| S:224 E:226 ||| .
There  ||| S:226 E:232 ||| EX
are  ||| S:232 E:236 ||| VBP
two  ||| S:236 E:240 ||| CD
types  ||| S:240 E:246 ||| NNS
of  ||| S:246 E:249 ||| IN
VIN  ||| S:249 E:253 ||| NNP
apart  ||| S:253 E:259 ||| RB
from  ||| S:259 E:264 ||| IN
their  ||| S:264 E:270 ||| PRP$
association  ||| S:270 E:282 ||| NN
with  ||| S:282 E:287 ||| IN
human  ||| S:287 E:293 ||| JJ
papillomavirus  ||| S:293 E:308 ||| NNS
( ||| S:308 E:309 ||| -LRB-
HPV ||| S:309 E:312 ||| NNP
) ||| S:312 E:313 ||| -RRB-
.  ||| S:313 E:315 ||| .
Undifferentiated  ||| S:315 E:332 ||| NNP
( ||| S:332 E:333 ||| -LRB-
usual ||| S:333 E:338 ||| JJ
)  ||| S:338 E:340 ||| -RRB-
vulval  ||| S:340 E:347 ||| FW
intraepithelial  ||| S:347 E:363 ||| FW
neoplasia  ||| S:363 E:373 ||| FW
is  ||| S:373 E:376 ||| VBZ
commonly  ||| S:376 E:385 ||| RB
associated  ||| S:385 E:396 ||| VBN
with  ||| S:396 E:401 ||| IN
carcinogenic  ||| S:401 E:414 ||| JJ
genotypes  ||| S:414 E:424 ||| NN
of  ||| S:424 E:427 ||| IN
HVP ||| S:427 E:430 ||| NNP
,  ||| S:430 E:432 ||| ,
whereas  ||| S:432 E:440 ||| FW
differentiated  ||| S:440 E:455 ||| FW
vulval  ||| S:455 E:462 ||| FW
intraepithelial  ||| S:462 E:478 ||| FW
neoplasia  ||| S:478 E:488 ||| FW
is  ||| S:488 E:491 ||| VBZ
not  ||| S:491 E:495 ||| RB
associated  ||| S:495 E:506 ||| VBN
with  ||| S:506 E:511 ||| IN
high-risk  ||| S:511 E:521 ||| JJ
genotypes  ||| S:521 E:531 ||| NN
of  ||| S:531 E:534 ||| IN
HPV ||| S:534 E:537 ||| NNP
.  ||| S:537 E:539 ||| .
The  ||| S:539 E:543 ||| DT
article  ||| S:543 E:551 ||| NN
presents  ||| S:551 E:560 ||| VBZ
an  ||| S:560 E:563 ||| DT
overview  ||| S:563 E:572 ||| NN
of  ||| S:572 E:575 ||| IN
VIN  ||| S:575 E:579 ||| NNP
occurence  ||| S:579 E:589 ||| NN
and  ||| S:589 E:593 ||| CC
epidemiology ||| S:593 E:605 ||| NN
,  ||| S:605 E:607 ||| ,
its  ||| S:607 E:611 ||| PRP$
classification  ||| S:611 E:626 ||| JJ
system  ||| S:626 E:633 ||| NN
and  ||| S:633 E:637 ||| CC
dia-gnostics ||| S:637 E:649 ||| JJ
.  ||| S:649 E:651 ||| .
In  ||| S:651 E:654 ||| IN
conclusion ||| S:654 E:664 ||| NN
,  ||| S:664 E:666 ||| ,
VIN  ||| S:666 E:670 ||| NNP
therapeutical  ||| S:670 E:684 ||| NN
possibilities  ||| S:684 E:698 ||| NNS
are  ||| S:698 E:702 ||| VBP
presented ||| S:702 E:711 ||| VBN
.  ||| S:711 E:713 ||| .
It  ||| S:713 E:716 ||| PRP
can  ||| S:716 E:720 ||| MD
be  ||| S:720 E:723 ||| VB
treated  ||| S:723 E:731 ||| VBN
with  ||| S:731 E:736 ||| IN
surgical  ||| S:736 E:745 ||| JJ
therapy  ||| S:745 E:753 ||| NN
( ||| S:753 E:754 ||| -LRB-
local  ||| S:754 E:760 ||| JJ
excision ||| S:760 E:768 ||| NN
,  ||| S:768 E:770 ||| ,
partial  ||| S:770 E:778 ||| JJ
vulvectomy ||| S:778 E:788 ||| NN
,  ||| S:788 E:790 ||| ,
vulvectomy ||| S:790 E:800 ||| NN
,  ||| S:800 E:802 ||| ,
laser  ||| S:802 E:808 ||| NN
vaporization ||| S:808 E:820 ||| NN
)  ||| S:820 E:822 ||| -RRB-
or  ||| S:822 E:825 ||| CC
medical  ||| S:825 E:833 ||| JJ
therapy  ||| S:833 E:841 ||| NN
( ||| S:841 E:842 ||| -LRB-
imiquimod ||| S:842 E:851 ||| LS
) ||| S:851 E:852 ||| -RRB-
.  ||| S:852 E:854 ||| .
